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ABSTRACT  
In this study, Annona muricata aqueous leaves extract was tested against dengue virus type 2. 
Firstly, the cytotoxicity of A. muricata was evaluated using a cell viability assay. The 
cytotoxicity of A. muricata on Vero cells was tested and the value of cytotoxic concentration, 
CC50 was ~2.5 mg/ml and the 50% Effective Concentration, EC50 was ~ 0.20 mg/ml. 
Selectivity index of extract against DENV-2 was more than 10 indicating potential as antiviral 
agent. Cells were pre- and post-treated with the extract and the viral inhibitory effect was 
investigated by observing the morphological changes, which were further confirmed the 
cellular viability evaluated by MTT technique. The results revealed that the post-treatment 
was more effective in inhibiting viral replication compared to pre-treatment. The findings 
indicated that A. muricata has good potential for prospective nature-based antiviral drug. 
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1.1. Dengue Virus  
Dengue virus (DENV) belongs to the family of Flaviviridae, which is a large family of viruses 
consisting of three genera; Flavivirus, Pestivirus and Hepacivirus. DENV is one of over 70 
members of the genus Flavivirus causing severe disease and mortality in both humans and 
animals [1]. Some of the most important emerging as well as resurging diseases worldwide 
can be allocated to the genus of the mosquito-borne flaviviruses.  
DENV circulates as four serotypes (DENV 1-4) and is mainly transmitted by mosquitoes 
Aedes aegypti and Aedes albopictus. It accounts for the highest disease and mortality rates 
amongst flaviviruses [2]. The four serotypes are closely related and share around 65% identity 
in their genome, which makes diagnosis difficult since they cross-react extensively in 
serological tests [3]. Although they are closely related, infection with one serotype only 
provides lifelong immunity for that specific serotype but does not provide cross-protective 
immunity against another serotype [4]. In contrast, subsequent infection with another serotype 
has been reported to be a risk factor for developing Dengue hemorrhagic fever (DHF) or 
Dengue shock syndrome (DSS) [5].  
1.2. Annona muricata 
Annona muricata L. (Magnoliales: Annonaceae) is a tropical plant species known for its 
edible fruit which has some medicinal merits, but also some toxicological effects. Traditional 
medicinal uses of A. muricata have been identified in tropical regions to treat diverse ailments 
such as fever, pain, respiratory and skin illness, internal and external parasites, bacterial 
infections, hypertension, inflammation, diabetes and cancer. More than 200 chemical 
compounds have been identified and isolated from this plant; the most important being 
alkaloids, phenols and acetogenins [6].   
 
2. METHODOLOGY 
2.1. Plant Materials and Extraction 
One hundred grams of A. muricata powder was dissolved in 1 liter of water and kept on the 
automatic shaker for 24 hours for extraction of water-soluble compounds. The extract was 
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filtered through Buchner funnel using vaccume pump connected to side arm flask. The filtrate 
thus collected was centrifuged at 3,000 rpm for 10 min to remove the particulate substances. 
The clear supernatant was freeze dried to obtain the fine powder. The freezedried powder was 
stored in the freezer till the use.  
2.2. Cell Lines and Growth Conditions 
Two types of cell lines were used in this study, C6/36 cells and Vero cells. C6/36 cells were 
maintained in L-15 medium (Sigma) supplemented with 5% fetal bovine serum (FBS) at 
28 °C. Vero cells (ATCC CCL- 81) was initiated from the kidney of a normal adult African 
green monkey were maintained in Dulbecco’s Modified Eagle Medium (DMEM) at 37 °C 
with 5% carbon dioxide. 
2.3. Virus Stock 
Dengue virus type-2 (DENV-2) used in this study is a prototype of the New Guinea C strain, a 
kind gift from the Faculty of Biosciences and Medical Engineering, Universiti Teknologi 
Malaysia. The virus stock was prepared in T75 cm2 tissue culture flasks by inoculating 70- 
80% confluent C6/36 cells with 200 L virus stock diluted in 2mL of medium supplemented 
with 1% FBS. After 1.5h of viral adsorption, a 1% FBS complete growth medium was added 
and the virus was allowed to propagate at 28 °C until cytopathic effects (CPE) were observed. 
The cells and the culture supernatant were then harvested by gentle pipetting, followed by 
centrifugation at 1500 rpm for 10 min. The viral supernatant was collected in 1 mL aliquots 
and was stored at -80 °C as a viral stock until further use.  
2.4. Cytotoxicity Test 
A cytotoxicity test was performed to determine the maximum nontoxic dose of the plant 
extracts. The Vero cells (2.5×105 cells/mL) were seeded into 96-well plates and incubated 
overnight at 37°C. Upon 80% confluence, the cells were treated with several concentrations 
of A. muricata aqueous leaves extract, ranging from 10 mg/ml to 0.31 mg/ml. Cells with only 
growth medium (DMEM) were used as negative control. After incubation of about 72h, the 
growth medium was discarded and replaced with 100 μL of 
3(4,5-dimethythiazol-2-yl)2,5-diphenyl tetrazolium bromide or MTT solution and incubated 
for 3h. After that, the MTT solution was discarded and formazan crystal was dissolved using 
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100 μL of dimethyl sulphoxide (DMSO) to lyse the cells. Colour development was detected 
using a microplate reader (TECAN Infinite 200 PRO) at 540 nm. The percentage of living 
cells was calculated by comparison with healthy untreated cells. 
2.5. Determination of Median Tissue Culture Infective Dose (TCID50) 
A total of 1.5 × 104 cells/well were seeded into 96-well plate and incubated at 37°C with 5% 
CO2. After 24 hours, a total volume of 100 μL of ten-fold serially diluted DENV-1 was 
inoculated into each well with 10 replicates for each dilution. Plates were further incubated at 
37°C for 5 days after which cytopathic effect (CPE) was observed microscopically under 
inverted microscope. To determine the TCID50 based on Karber method [23], the presence of 
CPE in each well was marked as ‘+’, while its absence was marked as ‘-’. The proportion of 
wells with CPE in each serially diluted DENV-1 was calculated and the TCID50 was 
estimated using the formula ‘Log TCID50 = L - d (s - 0.5) ’, whereby L = lowest dilution 
factor; d = difference between dilution steps; s = sum of proportion. The value of TCID50 
determined was applied in the antiviral assay. 
2.6. Antiviral Assay 
Screening for antiviral activity was performed using two different treatments, pre-treatment 
and post-treatment. To screen for antiviral activity, Vero cell monolayer were grown in 96 
well microtiter plates. Controls consisted of untreated infected, treated noninfected and 
untreated noninfected cells. The A. muricata aqueous leaves extract concentration tested was 
twice lower than the CC50 value in order to reduce the possibility of toxicity towards the 
cells.The cellular viability was evaluated by MTT technique. 
2.6.1. Pre-Treatment of Plant Extracts on DENV-2 Infected Cells 
Different concentrations of each extract were added in triplicate to Vero and C6/36 monolayer 
cells in 96-well plates for 24h. Subsequently, the extracts were removed by washing twice 
with PBS and the cells were challenged with 100 μL of DENV-2 at its TCID50. After viral 
infection for 1.5h, the cells were washed twice with PBS to remove any residual unbound 
viruses and were overlaid with culture medium containing 1% FBS complete growth medium. 
The cells were observed daily for any morphological changes, and at day 7 post infection, the 
cellular viability was evaluated by MTT technique. 
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2.6.2. Post-Treatment of DENV-2 Infected Cells with Plant Extracts 
In the post treatment assay, Vero cells grown in 96-well plates were infected with 100 μL of 
DENV-2 at its TCID50. After 1.5h of viral infection, the cells were washed twice with PBS to 
remove any residual unbound viruses. This was followed by the addition of serial dilutions of 
plant extracts in triplicate. Seven days after infection, the cellular viability was evaluated by 
MTT technique.  
2.7. Data Analysis 
The 50% cytotoxic concentration (CC50) and the 50% inhibitor concentration of the viral 
effect (EC50) for each extract were calculated from concentration-effect-curves after linear 
regression analysis. The therapeutic index or selective index is defined as CC50 over EC50. 
 
3. RESULTS AND DISCUSSION   
The leaves, bark, fruit and seed of A. muricata have been subject of countless medicinal uses 
[7]. Natives of Malaysia used A. muricata leaves to treat cutaneous (external) and internal 
parasites [8]. Interest in a large number of traditional natural products has increased [9-12]. It 
has been suggested that aqueous and ethanolic extracts from plants used in allopathic 
medicine are potential sources of antiviral and antitumor agents [13]. A. muricata was shown 
to exhibit antiviral activity against Herpes simplex virus-1 and Herpes simplex virus-2 
[14-15]. A. muricata also showed antibacterial activity against Gram positive and Gram 
negative bacteria. Currently, there is no anti dengue compound known to be isolated from A. 
muricata. The plant is known to contain flavonoids, alkaloids, saponins, tannins and 
glycosides involved in antimicrobial bioactivity. The mechanism of action is probably due to 
a synergism of these compounds [16]. In this study, the potential use of this plant to inhibit in 
vitro DENV-2 replication was investigated. 
To determine the nontoxic dose, Vero cells were exposed to two fold serially diluted extract at 
concentrations ranging from 0.31 to 10 mg/mL. The cytotoxicity assay result as presented in 
Fig. 1 shows the percentage of cell viability versus extract concentration. The estimated CC50 
value towards the Vero cells was ~ 2.5 mg/ml.  




Fig.1. Cytotoxicity assay of A. muricata extracts against Vero cells. The assay was performed 
after 48 hours of treatment with various concentrations of the plant extracts 
There is no signs of toxicity were observed in Vero cells when the extract were added at 
concentrations ranging from 0.31 to 1.25 mg/mL. The cells showed a healthy monolayer 
similar to the healthy control with no loss of monolayer and no obvious rounding, granulation 
or shrinking of cells was observed. However, the antiviral assay was pursued further as the 
concentration used in this assay was lower than the CC50 value. The EC50 value of the 
extracts tested against the DENV-2 was 0.20 mg/ml as shown in Fig. 2.  
 
Fig.2. Determination of extracts effective concentration (EC50) 
Cytotoxicity and anti-DENV-2 activity of plant extracts on Vero cells expressed as CC50 and 
EC50. The therapeutic index or selective index is defined as CC50 over EC50 [17]. The 
effectiveness of the extract as an antiviral compound expressed as selectivity index (SI) 
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revealed that the extract had greater SI value of 12.5. Any antimicrobial compound that has SI 
values higher than 10 (SI > 10) ensures the potential to be developed as an agent of antiviral 
drug [18]. The extracts were further evaluated for their prophylactic effect (pre-treatment) and 
the ability to inhibit replication following infection of the cells with the virus (post-treatment).  
Table 1 shows the comparisons in the cell survival when infected with DENV-2 and either 
pre-treated or post-treated cell with extract. The extract showed the capability to decrease 
viral replication more in the post-treated cell compared to the pre-treated cell. The ability of A. 
muricata to confer protection to the cells before DENV-2 infection was tested by pre-treating 
the cells with the extract for 24h prior to viral infection. Protection could be conferred through 
extracellular mechanisms. The extract might interrupt the interaction of several envelope 
glycol proteins with cell surface receptors requires for fusion of the virion envelope with a 
cell plasma membrane, resulting in ineffective viral infection [19]. Interestingly, 
post-treatment assay was conducted to investigate whether the intracellular activities such as 
DENV-2 viral RNA replication or viral protein translation and assembly in infected cells 
could be affected. The post treatment was shown to be more effective antiviral activities than 
the pre-treatment assay. Similar findings have been reported [20-22], where significant 
antiviral activity against various viruses was observed when the cells were post-treated with 
compounds or plant extracts following viral infection. This strategy is of great importance 
because it could be administered once the virus infection has been established in the cell. 
Table 1. Comparison between the infected DENV-2 pre-treated and post-treated cells with 
extract 




Post-Treated                 Pre-Treated 
% Cell Survival 
1.25 73 99 
0.63 71 85 
0.31 57 44 
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4. CONCLUSION  
A. muricata aqueous leaves extract can be cytotoxic, but at lower concentration than the CC50 
value, it has the potential to be an antiviral agent. The anti-DENV-2 activity occurred in the 
early stages of the replication, which was after the virus adsorption and penetration within the 
first 1.5 hours of infection. These species are good candidates for further activity-monitored 
fractionation to identify active principles.  
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